JWJie Wang

Jie Wang

*This is an algorithmically generated author record based on publicly available information.

Jie Wang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    INF2, an oncogenic protein in hepatocellular carcinoma (HCC)

    by Haibiao Wang, Man Lin, Fusang Ye, Hong Li, Meng Ye, Jie Wang

    Objectives This study investigated the expression level of INF2 and its carcinogenic effects in hepatocellular carcinoma. In addition, the mechanism of INF2 in hepatocellular carcinoma was explored. Materials and methods We analyzed the expression of INF2 and its prognosis and even correlation with clinicopathological characteristics based on the public database and HCC samples. Cloning formation experiment and flow cytometry were used to analyze the effect of INF2 expression level on the growth of HCC cells. Cell scratch experiment and Transwell migration experiment were applied to determine the role of INF2 expression level in the migration ability of HCC cells. TIMER2.0 database and TCGA-LIHC database were used to analyze the correlation between INF2 and PD-L1 in HCC. Results INF2 is aberrantly high expression in HCC samples. And high INF2 expression is associated with overall survival, liver cirrhosis and pathological differentiation. In vitro HCC cell models, upregulated expression of INF2 triggers the proliferation and migration of the HCC cell, while knockout of INF2 could counteract this effect. Knockdown of INF2 inhibited the proliferation and migration of HCC in vitro may via suppressing the Drp1-mediated mitochondrial fission. Moreover, INF2 was positively correlated with PD-L1 in HCC. Conclusions INF2 is an oncogenic protein in hepatocellular carcinoma, and targeting to INF2 may be beneficial to HCC patients with high expression of INF2.

  • Open Access

    The E3 Ligases in Cervical Cancer and Endometrial Cancer

    by Fengguang Zhai, Jie Wang, Weili Yang, Meng Ye, Xiaofeng Jin

    Endometrial (EC) and cervical (CC) cancers are the most prevalent malignancies of the female reproductive system. There is a global trend towards increasing incidence and mortality, with a decreasing age trend. E3 ligases label substrates with ubiquitin to regulate their activity and stability and are involved in various cellular functions. Studies have confirmed abnormal expression or mutations of E3 ligases in EC and CC, indicating their vital roles in the occurrence and progression of EC and CC. This paper provides an overview of the E3 ligases implicated in EC and CC and discusses their underlying mechanism. In addition, this review provides research advances in the target of ubiquitination processes in EC and CC.